Insiders Sarepta Therapeutics, Inc.

Equities

SRPT

US8036071004

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 02:30:00 10/12/2025 am IST			5-day change	1st Jan Change
22.17 ^USD	+1.42%		+8.30%	-81.77%

09/12	Sarepta Offers 'Attractive' Entry Point After Setbacks, Wedbush Says	MT
25/11	Sarepta Therapeutics, Inc. Announces Approval to Begin ENDEAVOR Cohort 8 to Evaluate Enhanced Immunosuppression Regimen as Part of Elevidys Gene Therapy for Non-Ambulant Individuals with Duchenne	CI

Insiders

Kalaris Therapeutics, Inc. Announces Executive Changes, Effective from November 3, 2025	03/11	CI
KalVista Pharmaceuticals Names Bilal Arif as COO, Linea Aspesi as Chief People Officer	06/10	MT
Vor Bio Appoints Adi Osovsky, S.J.D. as General Counsel	03/09	CI
Sarepta Therapeutics, Inc. Announces End of Employment for Bilal Arif as Executive Vice President, Chief Technical Operations Officer, Effective September 16, 2025	14/08	CI
Vinay Prasad returns to role as top vaccine regulator at FDA days after leaving US agency	09/08	RE
Vinay Prasad returns to role as top vaccine regulator at FDA days after leaving US agency	09/08	RE
US FDA's top vaccine official Vinay Prasad leaves agency after 3 months	30/07	RE
Sarepta Therapeutics, Inc Announces Management Changes	17/07	CI
US FDA names oncologist Vinay Prasad as top vaccine official	06/05	RE
Drugmaker shares sink after key FDA official ousted	31/03	RE
Pharma stocks sink after ouster of top FDA vaccine regulator	31/03	RE
Sarepta Therapeutics Insider Sold Shares Worth $1,310,820, According to a Recent SEC Filing	17/12	MT
Sarepta Therapeutics, Inc. Announces Appointment of Deirdre P. Connelly to Its Board of Directors	16/24/16	CI
Sarepta Therapeutics Insider Bought Shares Worth $4,955,728, According to a Recent SEC Filing	20/24/20	MT
Sarepta Therapeutics Insider Sold Shares Worth $1,848,795, According to a Recent SEC Filing	12/24/12	MT
Sarepta Therapeutics Insider Sold Shares Worth $385,480, According to a Recent SEC Filing	07/24/07	MT
Sarepta Therapeutics Insider Bought Shares Worth $2,001,800, According to a Recent SEC Filing	06/23/06	MT
Sarepta Therapeutics Insider Bought Shares Worth $3,940,500, According to a Recent SEC Filing	06/23/06	MT
Insider Buy: Sarepta Therapeutics	15/23/15	MT
Insider Buy: Sarepta Therapeutics	14/23/14	MT
Insider Buy: Sarepta Therapeutics	11/23/11	MT
Insider Sell: Sarepta Therapeutics	09/23/09	MT
Sarepta Therapeutics, Inc. Announces Executive Changes	03/22/03	CI
Insider Buy: Sarepta Therapeutics	15/22/15	MT
Insider Buy: Sarepta Therapeutics	22/22/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Sarepta Therapeutics, Inc.

Equities

SRPT

US8036071004

Pharmaceuticals

Insiders

Filters